Toponome imaging system: In situ protein network mapping in normal and cancerous colon from the same patient reveals more than five-thousand cancer specific protein clusters and their subcellular annotation by using a three symbol code

Journal of Proteome Research

Volumn 9, Issue 12, 2010, Pages 6112-6125

  Bhattacharya, Sayantan ^a,b   Mathew, George ^a   Ruban, Ernie ^a   Epstein, David B A ^b   Krusche, Andreas ^c   Hillert, Reyk ^c   Schubert, Walter ^c   Khan, Michael ^b  

^a GEORGE ELIOT HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR PROTEIN;

AGED; ARTICLE; CASE REPORT; CELL MEMBRANE; COLON CANCER; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEOMICS;

CLUSTER ANALYSIS; COLON; COLONIC NEOPLASMS; FLUORESCENT DYES; HUMANS; MICROSCOPY, FLUORESCENCE; PROTEINS; PROTEOMICS;

EID: 78649858759     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100157p     Document Type: Article

References (59)

1. Ricci-Vitiani, L.; Pagliuca, A.; Palio, E.; Zeuner, A.; De Maria, R. Colon cancer stem cells Gut 2008, 57 (4) 538-548
2. Adams, J. M.; Strasser, A. Is tumor growth sustained by rare cancer stem cells or dominant clones Cancer Res. 2008, 68 (11) 4018-4021
3. Adams, J. M. Role of "cancer stem cells" and cell survival in tumor development and maintenance Cold Spring Harb. Symp. Quant. Biol. 2008, 73, 451-459
4. O'Brien, C. A.; Pollett, A.; Gallinger, S.; Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 2007, 445 (7123) 106-110
5. Ricci-Vitiani, L. Identification and expansion of human colon-cancer-initiating cells Nature 2007, 445 (7123) 111-115
6. Dalerba, P. Phenotypic characterization of human colorectal cancer stem cells Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (24) 10158-10163
7. LaBarge, M. A.; Bissell, M. J. Is CD133 a marker of metastatic colon cancer stem cells J. Clin. Invest. 2008, 118 (6) 2021-2024
8. Pure, E.; Assoian, R. K. Rheostatic signaling by CD44 and hyaluronan Cell Signal. 2009, 21 (5) 651-655
9. Weichert, W.; Knosel, T.; Bellach, J.; Dietel, M.; Kristiansen, G. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival J. Clin. Pathol. 2004, 57 (11) 1160-1164
10. Friedenberger, M.; Bode, M.; Krusche, A.; Schubert, W. Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures Nat. Protoc. 2007, 2 (9) 2285-2294
11. Schubert, W. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy Nat. Biotechnol. 2006, 24 (10) 1270-1278
12. Schubert, W.; Gieseler, A.; Krusche, A.; Hillert, R. Toponome mapping in prostate cancer: detection of 2000 cell surface protein clusters in a single tissue section and cell type specific annotation by using a three symbol code J. Proteome Res. 2009, 8 (6) 2696-2707
13. Schubert, W. Exploring molecular networks directly in the cell Cytometry, Part A 2006, 69 (3) 109-112
14. Yatabe, Y.; Tavare, S.; Shibata, D. Investigating stem cells in human colon by using methylation patterns Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (19) 10839-10844
15. Moore, K. A.; Lemischka, I. R. Stem cells and their niches Science 2006, 311 (5769) 1880-1885
16. Capturing cancer stem cells. Nat. Med. 2008, 14 (8), 814.
17. Shen, L. MGMT promoter methylation and field defect in sporadic colorectal cancer J. Natl. Cancer Inst. 2005, 97 (18) 1330-1338
18. Giovannucci, E.; Ogino, S. DNA methylation, field effects, and colorectal cancer J. Natl. Cancer Inst. 2005, 97 (18) 1317-1319
19. Schubert, W. A three-symbol code for organized proteomes based on cyclical imaging of protein locations Cytometry, Part A 2007, 71 (6) 352-360
20. Tanious, F. A.; Veal, J. M.; Buczak, H.; Ratmeyer, L. S.; Wilson, W. D. DAPI (4′,6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sites Biochemistry 1992, 31 (12) 3103-3112
21. Mizrak, D.; Brittan, M.; Alison, M. R. CD133: molecule of the moment J. Pathol. 2008, 214 (1) 3-9
22. KojimaM. Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study Cancer Sci. 2008, 99 (8) 1578-1583
23. Horst, D.; Kriegl, L.; Engel, J.; Kirchner, T.; Jung, A. CD133 expression is an independent prognostic marker for low survival in colorectal cancer Br. J. Cancer 2008, 99 (8) 1285-1289
24. Nikolova, T. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro Differentiation 2007, 75 (2) 100-111
25. Horst, D. The cancer stem cell marker CD 133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer J. Pathol. 2009
26. Okegawa, T.; Pong, R. C.; Li, Y.; Hsieh, J. T. The role of cell adhesion molecule in cancer progression and its application in cancer therapy Acta Biochim. Pol. 2004, 51 (2) 445-457
27. Swart, G. W. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration Eur. J. Cell Biol. 2002, 81 (6) 313-321
28. Trzpis, M.; McLaughlin, P. M.; de Leij, L. M.; Harmsen, M. C. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule Am. J. Pathol. 2007, 171 (2) 386-395
29. Patel, B. B. Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: A risk factor for colon cancer Biochem. Biophys. Res. Commun. 2009, 378 (3) 344-347
30. Yue, S. Q.; Yang, Y. L.; Dou, K. F.; Li, K. Z. Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis World J. Gastroenterol. 2003, 9 (12) 2863-2865
31. Bahnassy, A. A. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients BMC Gastroenterol. 2004, 4, 22
32. Pignatelli, M. Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells Br. J. Cancer 1992, 66 (4) 629-634
33. Niewiarowska, J. DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth Cancer Gene Ther. 2009, 16 (9) 713-722
34. Hammarstrom, S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues Semin. Cancer Biol. 1999, 9 (2) 67-81
35. Blumenthal, R. D.; Hansen, H. J.; Goldenberg, D. M. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen) Cancer Res. 2005, 65 (19) 8809-8817
36. Tan, E. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer Surg. Oncol. 2009, 18 (1) 15-24
37. Li, Y. Y.; Hsieh, L. L.; Tang, R. P.; Liao, S. K.; Yeh, K. Y. Macrophage-derived interleukin-6 up-regulates MUC1, but down-regulates MUC2 expression in the human colon cancer HT-29 cell line Cell Immunol. 2009, 256 (1-2) 19-26
38. Matsuda, K. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma Jpn. J. Clin. Oncol. 2000, 30 (2) 89-94
39. Durbeej, M. Laminins Cell Tissue Res 2009
40. Cho, S.; Kim, E. CD36: a multi-modal target for acute stroke therapy J. Neurochem. 2009, 109 (Suppl 1) 126-132
41. Togashi, H.; Sakisaka, T.; Takai, Y. Cell adhesion molecules in the central nervous system Cell Adh. Migr. 2009, 3 (1) XXX
42. Golby, S. J.; Chinyama, C.; Spencer, J. Proliferation of T-cell subsets that contact tumour cells in colorectal cancer Clin. Exp. Immunol. 2002, 127 (1) 85-91
43. Needham, L. K.; Schnaar, R. L. The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (4) 1359-1363
44. Uusitalo, M.; Kivela, T. The HNK-1 carbohydrate epitope in the eye: basic science and functional implications Prog. Retin. Eye Res. 2001, 20 (1) 1-28
45. Moll, R.; Lowe, A.; Laufer, J.; Franke, W. W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies Am. J. Pathol. 1992, 140 (2) 427-447
46. Hernandez, B. Y. CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray Hum. Pathol. 2005, 36 (3) 275-281
47. Lagoudianakis, E. E. Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system J. Surg. Res. 2009, 155 (2) 183-190
48. Cottingham, K. The human toponome project. (Editorial) J. Proteome Res. 2008, 7, 1806
49. Schubert, W. Topological proteomics, toponomics, MELK-technology Adv. Biochem. Eng. Biotechnol. 2003, 83, 189-209
50. Abbott, A. Mapping togetherness (Research Highlight) (referring to Schubert et al. Nature 2006) Nature 2006, 443, 609
51. Schubert, W. On the origin of cell functions encoded in the toponome J. Biotechnol. XXX, XXX
52. Blumenthal, R. D.; Leon, E.; Hansen, H. J.; Goldenberg, D. M. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers BMC Cancer 2007, 7, 2
53. Moll, R. Molecular diversity of cytokeratins: significance for cell and tumor differentiation Acta Histochem. Suppl. 1991, 41, 117-127
54. Polley, A. C. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia Cancer Res. 2006, 66 (13) 6553-6562
55. Boman, B. M.; Huang, E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology J Clin Oncol 2008, 26 (17) 2828-2838
56. Chu, P. Characterization of a subpopulation of colon cancer cells with stem cell-like properties Int. J. Cancer 2008
57. Horst, D.; Kriegl, L.; Engel, J.; Kirchner, T.; Jung, A. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer Cancer Invest 2009, 27 (8) 844-850
58. Neuzil, J. Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name Biochem. Biophys. Res. Commun. 2007, 355 (4) 855-859
59. Shmelkov, S. V. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors J. Clin. Invest. 2008, 118 (6) 2111-2120